CXCL9 and inflammation: Moreover, chemotaxis analysis demonstrated that plasma from patients with coronary infarction induced chemotaxis of CD14+ monocytes (Figure 6E), thus sustained sequelae could be supported by vascular inflammation mediated by increased levels of CXCL9 and monocyte migration due to heart dysfunction during acute COVID-19.